Compare Fulford India with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs FRESENIUS KABI ONCO. - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA FRESENIUS KABI ONCO. FULFORD INDIA/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 398.8 22.1 1,801.9% View Chart
P/BV x 6.2 3.1 199.7% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 FULFORD INDIA   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
FRESENIUS KABI ONCO.
Mar-13
FULFORD INDIA/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs942176 535.2%   
Low Rs45079 573.2%   
Sales per share (Unadj.) Rs691.437.7 1,834.6%  
Earnings per share (Unadj.) Rs11.55.1 225.0%  
Cash flow per share (Unadj.) Rs15.46.7 228.4%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.042.5 893.2%  
Shares outstanding (eoy) m3.90158.23 2.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.4 29.8%   
Avg P/E ratio x60.725.0 243.1%  
P/CF ratio (eoy) x45.318.9 239.4%  
Price / Book Value ratio x1.83.0 61.2%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,71420,135 13.5%   
No. of employees `0000.41.2 38.5%   
Total wages/salary Rs m505703 71.8%   
Avg. sales/employee Rs Th6,073.05,176.2 117.3%   
Avg. wages/employee Rs Th1,137.4610.4 186.3%   
Avg. net profit/employee Rs Th100.7699.6 14.4%   
INCOME DATA
Net Sales Rs m2,6965,963 45.2%  
Other income Rs m12518 696.7%   
Total revenues Rs m2,8225,981 47.2%   
Gross profit Rs m-461,430 -3.2%  
Depreciation Rs m15258 5.9%   
Interest Rs m10-26 -36.5%   
Profit before tax Rs m541,216 4.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m10342 2.8%   
Profit after tax Rs m45806 5.5%  
Gross profit margin %-1.724.0 -7.2%  
Effective tax rate %17.728.1 62.8%   
Net profit margin %1.713.5 12.3%  
BALANCE SHEET DATA
Current assets Rs m1,7385,102 34.1%   
Current liabilities Rs m5452,385 22.8%   
Net working cap to sales %44.345.6 97.2%  
Current ratio x3.22.1 149.2%  
Inventory Days Days48150 32.3%  
Debtors Days Days4113 3.8%  
Net fixed assets Rs m125,148 0.2%   
Share capital Rs m39158 24.7%   
"Free" reserves Rs m1,4436,556 22.0%   
Net worth Rs m1,4826,732 22.0%   
Long term debt Rs m0952 0.0%   
Total assets Rs m2,07710,388 20.0%  
Interest coverage x6.7-45.8 -14.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.30.6 226.2%   
Return on assets %2.67.5 34.8%  
Return on equity %3.012.0 25.2%  
Return on capital %4.314.6 29.5%  
Exports to sales %074.5 0.0%   
Imports to sales %24.524.8 98.7%   
Exports (fob) Rs mNA4,441 0.0%   
Imports (cif) Rs m6591,477 44.6%   
Fx inflow Rs m175,298 0.3%   
Fx outflow Rs m6731,772 38.0%   
Net fx Rs m-6563,525 -18.6%   
CASH FLOW
From Operations Rs m901,274 7.1%  
From Investments Rs m105-1,204 -8.7%  
From Financial Activity Rs m-14-196 7.2%  
Net Cashflow Rs m181-126 -142.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 81.0 92.6%  
Indian inst/Mut Fund % 3.8 0.3 1,266.7%  
FIIs % 0.1 9.6 1.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 9.1 233.0%  
Shareholders   4,783 42,599 11.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS